Home
Conditions
Red-Cell Aplasia, Pure

Clinical trial condition

Red-Cell Aplasia, Pure

Explore clinical trials studying Red-Cell Aplasia, Pure. Study availability and eligibility vary by location and protocol.

38 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Red-Cell Aplasia, Pure trial results

Completed

A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload

NCT00171821

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +15 more
Locations: Novartis Investigative Site Adelaide, Australia

Novartis Investigative Site Camperdown, Australia

Novartis Investigative Site Clayton, Australia

Novartis Investigative Site Melbourne, Australia

View all 97 locations

View Trial Details

Completed

Bone Marrow Transplant With Abatacept for Non-Malignant Diseases

NCT01917708

Conditions: Albinism, Anemia, Anemia, Aplastic, +80 more
Locations: Children's Healthcare of Atlanta Atlanta, Georgia, United States

View Trial Details

Completed

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01529827

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +179 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs

NCT00957931

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +16 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Stem Cell Transplant for Bone Marrow Failure Syndromes

NCT00176878

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +20 more
Locations: University of Minnesota Medical Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders

NCT00301834

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +26 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

NCT00061763

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +28 more
Locations: Children's Hospital Oakland Oakland, California, United States

Stanford Hospital Stanford, California, United States

Northwest Medical Specialists Arlington Heights, Illinois, United States

Children's Hospital Boston Boston, Massachusetts, United States

View Trial Details

Completed

Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias

NCT00244010

Conditions: Amegakaryocytic Thrombocytopenia, Anemia, Anemia, Aplastic, +14 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload

NCT00673608

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +22 more
Locations: Novarts Investigative Site Adelaide, Australia

Novarts Investigative Site Brisbane, Australia

Novarts Investigative Site Melbourne, Australia

Novarts Investigative Site Sydney, Australia

View Trial Details

Completed

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

NCT00600938

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +24 more
Locations: Novartis Investigative Site Toronto, Ontario, Canada

Novartis Investigative Site Nanning, Guangxi, China

Novartis Investigative Site Limassol, Cyprus

Novartis Investigative Site Al Mansurah, Egypt

View all 21 locations

View Trial Details

Red-Cell Aplasia, Pure

Red-Cell Aplasia, Pure trial results

Related conditions